Thursday, October 12, 2017

Ebola vaccines from Merck, Glaxo show promise

  1. Ebola vaccines from Merck, Glaxo show promise  MarketWatch
  2. Liberia trial finds Ebola vaccines yield year-long immune response  CIDRAP
  3. Experimental Ebola vaccines elicit year-long immune response  National Institutes of HealthFull coverage

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Headlines